glp 1 amylin Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus Amylin analogues for weight loss:

Eng et al., J Biol Chem, 1992 Parkes et al., Diabetes Care, 2013 #GLP1 #DrugDiscovery #FromBenchToBedside #NephMadness #MedicalEducation #Endocrinology #Nephrology To view or add a comment, sign in More Relevant Posts Medicos quick Platelets MCQ

Alpha lipoic acid (ALA) - A strong antioxidant that works with glutathione to protect skin cells and reduce signs of ageing + dullness + inflammation

The study evaluated body weight changes over 24 and 48 weeks across various treatment groups, along with a series of metabolic indicators such as glycated hemoglobin and triglyceride levels

An integrated benefit-risk assessment of cobalt-containing alloys used in medical devices: Implications for regulatory requirements in the European Union

Its main biological role is to act as a copper chaperoneit transports and delivers copper to cells that need it